Ve² Consult SRL
Ve² Consult reported total assets of 140,720 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of Ve² Consult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -45 % Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ve² Consult's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 25,442 € | ||||
| Equity | 89,258 € | ||||
| Cash | 132,749 € | ||||
| EBITDA | 26,293 € | ||||
| Total assets | 140,720 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 28 Apr 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Ve² Consult's financial analysis
- Solvency63.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ve² Consult
Ve² Consult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.113.661
- VAT number
- BE0837113661
- Peppol
- Registered · 0208:0837113661 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jun 2011
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ve² Consult (SRL) has been based in Mechelen since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,442 € and equity of 89,258 €; its revenue is not published. Its solvency stands at 63.4%, above the median of its sector (44.2%).
Companies similar to Ve² Consult
Companies in the same business, of comparable size and area, outside its group.
- BERA Business and other management consultancy activities Antwerp · balance sheet 140,519 €
- CosProf Studio Business and other management consultancy activities Niel · balance sheet 120,568 €
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- Swilem Pharmaceuticals Business and other management consultancy activities Evere · balance sheet 292,979 €
- Galeni K. Business and other management consultancy activities Zutendaal · balance sheet 67,285 €
- Lintström Business and other management consultancy activities Schilde · balance sheet 64,321 €
- ENNC Retail sale of pharmaceutical products Oud-Heverlee · balance sheet 149,458 €
- Management Consulting Pharma Retail sale of pharmaceutical products Perwez · balance sheet 155,710 €
Frequently asked questions about Ve² Consult
What is the revenue of Ve² Consult?
Ve² Consult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ve² Consult?
In Belgium, the VAT number is the company number prefixed with BE: BE0837113661 for Ve² Consult, if the company is VAT-registered. Its company number (CBE) is 0837.113.661.
Where is the registered office of Ve² Consult?
According to the CBE register, the registered office of Ve² Consult is in 2811 Mechelen.
What is the equity of Ve² Consult?
At the close of the 2025 financial year, the equity of Ve² Consult amounts to 89,258 €, a solvency of 63.4% of total assets.
Who manages Ve² Consult?
The register lists 2 active mandates at Ve² Consult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ve² Consult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →